Valuation : SMS Pharmaceuticals Limited

Market Cap 35.11B 369M 317M 298M 272M 511M 515M 3.53B 1.37B 17.81B 1.39B 1.36B 58.95B P/E 2024
30.3x
P/E 2025 27.3x
Enterprise Value 37.8B 397M 342M 321M 293M 550M 554M 3.8B 1.48B 19.18B 1.49B 1.46B 63.47B EV / Sales 2024
2.47x
EV / Sales 2025 2.75x
Free-Float
23.43%
Yield 2024
0.22%
Yield 2025 0.19%
1 day+4.56%
1 week+4.26%
Current month-0.69%
1 month-0.58%
3 months+0.51%
6 months+0.45%
Current year+19.81%
1 week 349.95
Extreme 349.95
378.1
1 month 349.95
Extreme 349.95
385.5
Current year 293.55
Extreme 293.55
446.5
1 year 230.75
Extreme 230.75
446.5
3 years 111.95
Extreme 111.95
446.5
5 years 54.5
Extreme 54.5
446.5
10 years 23.55
Extreme 23.55
446.5
Manager TitleAgeSince
Chief Executive Officer 66 1990-08-29
Director of Finance/CFO - 2017-09-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 1990-08-29
Director/Board Member 38 2020-06-04
Director/Board Member 48 2018-05-28
Change 5-day change 1-year change 3-year change Capi.($)
+4.56%+4.26% - - 348M
+3.38%+4.33%+24.48%+78.02% 48.2B
+0.66%+0.45%+57.74%+122.48% 39.97B
-2.49%+3.69%+18.37%+84.89% 12.43B
-1.00%-1.61%-11.34%+14.00% 12.03B
+0.19%-.--%+29.35%+150.00% 9.35B
-1.80%-1.50%+25.41%+48.78% 7.75B
-1.39%+6.99%+28.90%+228.32% 7.43B
-0.26%+0.10%+47.89%-11.58% 7.22B
-0.84%-2.36%-36.62%+16.04% 5.3B
Average +0.10%+2.12%+20.46%+81.22% 16.63B
Weighted average by Cap. +0.79%+1.36%+29.51%+89.24%

Financials

2024 2025
Net sales 7.09B 74.54M 64.14M 60.26M 55.01M 103M 104M 713M 278M 3.6B 280M 274M 11.91B 7.83B 82.27M 70.78M 66.5M 60.71M 114M 115M 787M 306M 3.97B 309M 302M 13.14B
Net income 498M 5.24M 4.51M 4.23M 3.86M 7.26M 7.31M 50.12M 19.5M 253M 19.66M 19.23M 837M 691M 7.27M 6.25M 5.87M 5.36M 10.07M 10.14M 69.54M 27.05M 351M 27.28M 26.69M 1.16B
Net Debt 2.45B 25.71M 22.12M 20.79M 18.98M 35.63M 35.88M 246M 95.73M 1.24B 96.54M 94.43M 4.11B 2.69B 28.3M 24.35M 22.88M 20.88M 39.21M 39.49M 271M 105M 1.37B 106M 104M 4.52B
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,470
Date Price Change Volume
26-08-31 ₹371.60 +4.56% 7,393
26-08-28 ₹355.40 -2.03% 3,688
26-08-27 ₹362.75 +1.37% 8,187
26-08-26 ₹357.85 +0.35% 7,434
26-08-25 ₹356.60 +0.72% 4,069

Annual profits - Rate of surprise